Capital One National Association’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
– Sell
-14,612
Closed -$782K – 531
2014
Q2
$782K Sell
14,612
-29
-0.2% -$1.59K 0.07% 263
2014
Q1
$883K Sell
14,641
-62
-0.4% -$3.61K 0.09% 264
2013
Q4
$780K Sell
14,703
-337
-2% -$16.9K 0.08% 268
2013
Q3
$696K Sell
15,040
-1,286
-8% -$59K 0.07% 276
2013
Q2
$670K Buy
+16,326
New +$699K 0.07% 271

Other funds holding CRL

Capital One National Association's CRL Position: Q3 2014 in Review

Capital One National Association sold out of Charles River Laboratories (CRL) in Q3 2014, closing a stake of 14,612 shares — an estimated $782K sold.

Capital One National Association first reported a position in CRL in Q2 2013 and held it in 5 quarters. The position peaked at $883K in Q1 2014. 255 funds tracked by Wall St. Rank hold CRL as of Q3 2014.

  • Capital One National Association reported no remaining Charles River Laboratories position as of Q3 2014 after selling out during the quarter.
  • Capital One National Association sold 14,612 Charles River Laboratories shares in Q3 2014, an estimated $782K.
  • Capital One National Association first reported a position in Charles River Laboratories in Q2 2013 and held it in 5 quarters.
  • Capital One National Association's Charles River Laboratories position peaked at $883K in Q1 2014.
  • 255 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2014.

Based on Capital One National Association's 13F filing for Q3 2014, filed 14 Oct 2014.